The successful use of nitric oxide (NO) inhalation in a critically ill
neonate with Ebstein's anomaly of the tricuspid valve is reported for
the first time. This use of inhaled NO therapy suggests a therapeutic
intervention that directly addresses the pathophysiologic process of
severe neonatal Ebstein's anomaly.